Sort
15,842 grants matching “pancreatic cancer”
Clinical Photodynamic Therapy for Pancreatic and Biliary Tract Cancer
$219,611Stephen Pereira · Massachusetts General Hospital · P01 · FY2010 · CA
Mechanisms Controlling Epithelial Homeostasis
$219,600Alana M O'Reilly · Research Inst Of Fox Chase Can Ctr · R01 · FY2017 · HD
A novel murine model for metastatic islet cell pancreas cancer
$219,599Kenneth W Gross · Roswell Park Cancer Institute Corp · R21 · FY2012 · CA
The role of LKB1 in the maintenance of genomic stability.
$219,590Zhi-Xiang Xu · University Of Alabama At Birmingham · R01 · FY2013 · CA
Regulation of Food Intake and Body Weight by GLP-1
$219,568Roger Reidelberger · Creighton University · R01 · FY2008 · DK
Novel Focal Adhesion Kinase autophosphorylation inhibitors against pancreatic cancer
$219,534Vita M Golubovskaya · Curefaktor Pharmaceuticals, Llc · R41 · FY2014 · CA
Using p53 Knock-In Mice to Understand p53's Role in Pancreatic Cancer
$219,494Laura D Attardi · Stanford University · R21 · FY2010 · CA
ECT2 Isoform Switch in Pancreatic Cancer.
$219,491Verline Justilien · Mayo Clinic Jacksonville · R21 · FY2025 · CA
Deiminated molecules as markers for developing pancreatic cancer - A1
$219,491Peter Storz · Mayo Clinic Jacksonville · R21 · FY2025 · CA
ULK1 Inhibitor in Combination with Immune Checkpoint Blockade in PancreaticCancer
$219,491Jeffrey Paul Mackeigan · Michigan State University · R21 · FY2023 · CA
Modulation of the human pancreatic microenvironment by combined cytokine and immune checkpoint blockade
$219,491Gregory B. Lesinski · Emory University · R21 · FY2022 · CA
Transplantation Tolerance Induced by Linked Suppression
$219,462Torrey Pines Inst For Molecular Studies · R21 · FY2001 · DK
Angiogenin and its small RNA products in glioblastoma and brain microenvironment
$219,395Anna M. Krichevsky · Brigham And Women'S Hospital · R21 · FY2017 · NS
P2 - Markers of Pancreatic Cancer Using a Glycoproteomic Approach
$219,392Mack T Ruffin · University Of Michigan At Ann Arbor · P50 · FY2011 · CA
Single Circulating Vesicle Analysis for Early Cancer Detection
$219,240Ralph Weissleder · Massachusetts General Hospital · R21 · FY2020 · CA
Single Circulating Vesicle Analysis for Early Cancer Detection
$219,240Ralph Weissleder · Massachusetts General Hospital · R21 · FY2019 · CA
NEW GENETIC MARKERS FOR PANCREATIC CANCER
$219,161Johns Hopkins University · P50 · FY2000 · CA
CORE--HUMAN TISSUE RESOURCE AND LOGISTICS
$219,161Johns Hopkins University · P50 · FY2000 · CA
MARKERS FOR RISK IN FAMILIAL PANCREATIC CANCER
$219,161Johns Hopkins University · P50 · FY2000 · CA
CORE--COLORECTAL AND PANCREATIC CANCER PATIENT REGISTRY
$219,161Johns Hopkins University · P50 · FY2000 · CA
TARGETS FOR SCREENING IN PANCREATIC NEOPLASIA
$219,161Johns Hopkins University · P50 · FY2000 · CA
IDENTIFICATION OF T CELL RECOGNITION TARGETS ON PANCREATIC ADENOCARCINOMA
$219,161Johns Hopkins University · P50 · FY2000 · CA
Microenvironmental Transport for Immunotherapy in Pancreatic Cancer
$219,101Jason B Fleming · Methodist Hospital Research Institute · U54 · FY2017 · CA
Defining SPINK1 as a tumor driver and therapeutic target in ovarian cancer
$218,961Evette S Radisky · Mayo Clinic Jacksonville · R21 · FY2013 · CA
Genetic Pathways Governing Pancreatic Ductal Adenocarcinoma
$218,959Ronald Anthony Depinho · Dana-Farber Cancer Inst · P01 · FY2009 · CA